Three market segments, ordered by near-term revenue potential.
Primary Revenue Benefits Advisors & Brokers
The benefits advisory market is large and fragmented — thousands of small-to-midsize firms advising employers on health plan design, network selection, and cost management. They need rate benchmarking data that currently requires expensive enterprise contracts or manual research.
Each advisor serves multiple employer clients. A single subscription generates value across a portfolio — multiplicative reach from a single sale. Sales cycles are shorter than health system deals, and price sensitivity is lower because the data directly enables revenue-generating advisory work.
Revenue model: SaaS subscription (advisor tier) + API access for workflow integration
Secondary Revenue Health Systems & Compliance Teams
Hospitals need to monitor their own CMS compliance and benchmark against competitors. With penalties at $5,500/day, compliance is budget-justified — and compliance officers are a defined buyer persona with purchasing authority.
ClearPrice tracks 141 hospitals with CMS enforcement records and 28 with published penalty documents. This enforcement intelligence is the foundation for a compliance monitoring product.
Revenue model: SaaS subscription (admin tier) + compliance monitoring add-on
Demand Engine Consumers — Organic Traffic & Brand
The consumer app is not the primary revenue target. It is the organic traffic engine that powers the entire go-to-market strategy.
Quality-price inversion — the finding that hospitals with higher quality ratings often charge less — is a counterintuitive, shareable insight. It drives organic discovery, media coverage, and word-of-mouth. Consumer engagement generates brand awareness, SEO authority, and inbound leads for the B2B segments that monetize.
Revenue model: Free tier; future premium features for detailed OOP estimates and plan comparison
| Stream | Source | Timeline |
|---|
| SaaS subscriptions | Advisor + admin tiers (monthly/annual) | Q2-Q3 2026 |
| API licensing | Data access for platform integrations | Q3 2026 |
| Data partnerships | Payer/PBM licensing potential | Q4 2026+ |
| Consumer premium | Freemium conversion on patient app | 2027+ |
Current Status
ClearPrice is pre-revenue and product-led. The platform is built and operational — three products live in production, data pipeline running weekly. First broker pilot conversations targeted for Q2 2026.
